Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-09 Sale | 2023-08-11 5:00 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 75,000 | $30.73 | $2,305,028 | 840,390 (Indirect Direct) | View |
| 2023-07-12 Sale | 2023-07-14 6:09 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 75,000 | $31 | $2,325,214 | 915,390 (Indirect Direct) | View |
| 2022-11-08 Sale | 2022-11-10 5:04 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 24,500 | $43.47 | $1,065,013 | 990,390 (Indirect Direct) | View |
| 2022-11-02 Sale | 2022-11-04 7:16 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 5,500 | $43.06 | $236,846 | 1,014,890 (Indirect Direct) | View |
| 2022-08-01 Sale | 2022-08-03 7:12 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 30,000 | $43.19 | $1,295,727 | 1,020,390 (Indirect Direct) | View |
| 2021-03-03 Sale | 2021-03-05 7:04 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 100,000 | $44.78 | $4,478,450 | 250,390 (Indirect Direct) | View |
| 2021-03-02 Sale | 2021-03-04 7:00 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 100,000 | $46.94 | $4,694,090 | 350,390 (Indirect Direct) | View |
| 2020-06-18 Purchase | 2020-06-23 9:21 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 2,950 | $28 | $82,600 | 797,705 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-08 Gift | 2023-08-08 5:37 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 1,650 | $0 | 351,350 (Indirect) | View |
| 2021-05-07 Conversion | 2021-05-11 9:05 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 1,100,000 | $0 | 1,346,858 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:53 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 440,000 | $0 | 827,636 (Indirect) | View |
| 2020-06-18 Conversion(A) | 2021-01-05 9:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 26,587 | $0 | 26,963 (Indirect) | View |
| 2020-06-15 Option Award(A) | 2021-01-05 9:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 2,605 | $0 | 26,963 (Indirect) | View |
Ownership(A) | 2021-01-05 9:49 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 0 | $0 | 26,050 (Indirect) | View |
| 2020-06-18 Conversion | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 25,597 | $0 | 797,705 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 772,754 | $0 | 797,705 (Indirect) | View |
Ownership(A) | 2020-06-17 8:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 0 | $0 | 48,000 (Direct) | View |
Ownership | 2020-06-15 9:27 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 0 | $0 | 4,502,540 (Indirect) | View |